By Dr Benjamin Daniels

Preprints

Hurlbert M; Daniels B; Brett J; Murnion B, 2026, Rituximab dispensing after unrestricted subsidised listing in Australia: a controlled interrupted time series and single-centre audit, http://dx.doi.org/10.22541/authorea.15006334/v1

Daniels B; Girosi F; Tervonen H; Kiely BE; Lord SJ; Houssami N; Pearson S-A, Adherence to prescribing restrictions for HER2-positive metastatic breast cancer in Australia: a national population-based observational study (2001-2016), http://dx.doi.org/10.1101/324343

Hong S; Daniels B; Leeuwen MT; Pearson S-A; Vajdic CM, Incidence And Risk Factors of Hypertension Therapy In Australian Cancer Patients Treated With Vascular Signalling Pathway Inhibitors, http://dx.doi.org/10.21203/rs.3.rs-1006781/v1

Zoega H; Falster MO; Gillies MB; Litchfield M; Camacho X; Bruno C; Daniels B; Donnolley N; Havard A; Schaffer AL; Chambers G; Degenhardt L; Dobbins T; Gisev N; Ivers R; Jorm L; Liu B; Vajdic CM; Pearson S-A, The Medicines Intelligence Data Platform: A population-based data resource from New South Wales, Australia, http://dx.doi.org/10.1101/2024.04.29.24306520

Back to profile page